A recent study by IQVIA, developed using IMRD and powered by Dexter, explores the association between glucagon-like peptide-1 (GLP-1) receptor agonists and hepato-pancreato-biliary diseases in individuals with T2D. This research was presented at ISPOR Europe in November 2025.

Population health-based research is vital for identifying effective strategies to tackle healthcare challenges and support patients managing chronic conditions such as diabetes. Access to robust, real-world data is essential as it enables researchers to study these conditions and uncover actionable insights. One, such dataset is IQVIA Medical Research Data (IMRD), a longitudinal primary care dataset capturing millions of non-identified patient records across England.

‘As the burden of diabetes continues to grow globally, the imperative to harness real-world data has never been clearer. By automating complex epidemiological workflows, such as data cleaning, extraction, and feasibility analysis, Dexter enables researchers to conduct observational studies and generate clinical evidence in minutes rather than months.’